CBD has stronger clinical evidence for reducing anxiety, but CBG shows early promise and may work through overlapping pathways. No head-to-head trial has directly compared the two, so calling one definitively “better” isn’t possible yet. What we can do is look at how each one works in the brain, what the human studies actually show, and where the gaps in evidence still are.
How CBD Reduces Anxiety
CBD’s anxiety-reducing effects are primarily driven by its interaction with serotonin receptors, specifically the 5-HT1A receptor. Serotonin is the same neurotransmitter targeted by common prescription antidepressants (SSRIs), so CBD appears to tap into a well-understood anxiety pathway. When researchers blocked the 5-HT1A receptor in animal studies, CBD’s calming effects disappeared entirely, while its pain-relieving effects only partially diminished. That tells us the serotonin system isn’t just one of many pathways for CBD’s anxiety relief; it’s the central one.
What makes this particularly interesting is how CBD behaves with repeated use. After seven days of treatment in one study, CBD caused a desensitization of serotonin autoreceptors, a process that essentially allows more serotonin signaling over time. This is the same basic mechanism that makes SSRIs more effective after a few weeks of daily use rather than on the first dose. It suggests CBD’s anxiety benefits may build with consistent use rather than being a one-time effect.
How CBG Reduces Anxiety
CBG also interacts with the 5-HT1A serotonin receptor, but its mechanism appears to be more complex and less direct. Research published in Frontiers in Pharmacology found that CBG reduces the inhibitory effects of drugs that activate both serotonin and adrenergic receptors in brain regions linked to stress and arousal. The adrenergic system governs your fight-or-flight response, and some existing anxiety medications work by regulating those same receptors. CBG’s ability to modulate both systems could theoretically give it a broader calming profile, though this has only been demonstrated in brain tissue studies so far.
When researchers tested CBG’s anxiety effects in live animals, the calming behavior was blocked by a serotonin receptor antagonist, suggesting that, like CBD, CBG’s anxiolytic effects ultimately depend on serotonin signaling. The adrenergic component is intriguing but hasn’t been confirmed as a meaningful contributor to anxiety relief in living subjects yet.
What the Human Evidence Shows
This is where the comparison tilts heavily toward CBD. Multiple human clinical trials have examined CBD for anxiety, and it has been studied in people with generalized anxiety, social anxiety disorder, and anxiety related to chronic pain. The results have generally been positive, which is why CBD is widely discussed as an anxiolytic compound in the medical literature.
CBG’s human evidence is far thinner. The first clinical trial examining CBG’s acute effects on anxiety was a double-blind, placebo-controlled crossover study with 34 healthy adults. Participants took either 20 mg of hemp-derived CBG or a placebo tincture, with a one-week washout period between sessions. CBG produced significant reductions in both anxiety and stress compared to placebo. That’s a meaningful result, but it’s a single small study in healthy volunteers, not people with anxiety disorders. Prior to this trial, only one other human study involving CBG had been published, and it tested a combination product (CBG with CBD and a terpene) for muscle soreness, not anxiety.
So the honest answer is: CBD has years of clinical research supporting its use for anxiety, while CBG has one promising but preliminary trial. If you’re choosing based on evidence alone, CBD is the safer bet right now.
Side Effects and Safety
CBD’s most commonly reported side effects include fatigue, changes in appetite, and digestive discomfort. These tend to be mild, especially at lower doses, but CBD can interact with certain medications by affecting how your liver processes them.
CBG appears to be well tolerated based on the limited data available. Animal studies found no eye-related or brain-related toxic effects, which have occasionally been observed with other cannabinoids. Some CBG users report improved sleep, though this hasn’t been confirmed in controlled studies. One notable difference: CBG has been shown to reduce appetite and promote weight loss by blocking CB1 receptors, while CBD’s appetite effects are more variable. If appetite suppression is a concern for you, that’s worth noting.
Neither compound is intoxicating, and neither produces the “high” associated with THC.
Combining CBD and CBG
Because both compounds interact with serotonin receptors through slightly different mechanisms, some people use them together. The concept behind this is often called the “entourage effect,” which refers to the idea that cannabinoids, terpenes, and other plant compounds may produce enhanced effects when used in combination rather than in isolation. Synergistic interactions between different cannabinoids have been proposed in the scientific literature, though the specific combination of CBD and CBG for anxiety hasn’t been studied directly in any clinical trial.
Full-spectrum hemp products often contain small amounts of CBG alongside CBD, so many people using CBD oil are already getting trace exposure to CBG without realizing it. Whether those small amounts are enough to meaningfully contribute to anxiety relief is unknown.
Product Quality and Regulation
Neither CBD nor CBG is FDA-approved for anxiety. CBD is FDA-approved only for certain seizure disorders. Hemp-derived cannabinoids are legal at the federal level but are not regulated the way prescription medications are, which creates real quality control issues. A recent study found that some commercially available CBD products were inaccurately labeled regarding whether they contained CBD isolate, broad-spectrum, or full-spectrum formulations. Mislabeling can mean unexpected THC content or inconsistent cannabinoid doses from bottle to bottle.
If you’re trying either compound, look for products that provide third-party certificates of analysis showing exactly what’s in the bottle. This is especially important for CBG products, which are newer to the market and produced by fewer manufacturers.
Dosage Differences
CBD doses in anxiety research have typically ranged from around 25 mg to several hundred milligrams per day, depending on the study and the severity of symptoms. Many people start at the lower end and adjust upward.
The only controlled CBG trial for anxiety used just 20 mg and found significant effects, suggesting CBG may be active at lower doses than CBD for this purpose. However, with only one study to draw from, it’s too early to establish a reliable dosage range. Starting low and increasing gradually is a reasonable approach for either compound.